{"product_id":"actemra-tocilizumab","title":"Actemra (Tocilizumab)","description":"\u003cdiv\u003e\n\n\n\u003cp\u003e\u003cspan\u003e\n\u003ca rel=\"nofollow\" href=\"https:\/\/www.rxlist.com\/rheumatoid_arthritis_ra_medications\/drugs-condition.htm\"\u003eRheumatoid arthritis\u003c\/a\u003e, \u003ca rel=\"nofollow\" href=\"https:\/\/www.rxlist.com\/giant_cell_arteritis_gca_or_temporal_arteritis\/article.htm\"\u003eGiant Cell Arteritis\u003c\/a\u003e and \u003ca rel=\"nofollow\" href=\"https:\/\/www.rxlist.com\/cytokine\/definition.htm\"\u003eCytokine\u003c\/a\u003e Release Syndrome. Actemra may be used alone or with other medications.Actemra belongs to a class of drugs called DMARDs, Immunomodulators; \u003ca rel=\"nofollow\" href=\"https:\/\/www.rxlist.com\/monoclonal\/definition.htm\"\u003eMonoclonal\u003c\/a\u003e Antibodies.\u003c\/span\u003e\u003c\/p\u003e\n\u003cspan\u003e\u003cspan\u003eIn clinical t\u003c\/span\u003erials of hospitalized patients with COVID-19, Actemra in addition to the routine care patients receive for treatment of COVID-19, which included corticosteroid therapy, \u003c\/span\u003e\u003cb\u003ewas shown to reduce the risk of death through 28 days of follow-up and decrease the amount of time patients remained hospitalized\u003c\/b\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eRheumatoid arthritis\u003c\/b\u003e\u003c\/li\u003e\n\u003cli\u003e\n\u003ch4\u003eGiant Cell Arteritis (GCA)\u003c\/h4\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ch4\u003eSystemic Juvenile Idiopathic Arthritis (SJIA)\u003c\/h4\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ch4\u003ePolyarticular Juvenile Idiopathic Arthritis (PJIA)\u003c\/h4\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ch4\u003eCytokine Release Syndrome (CRS)\u003c\/h4\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe most common side effects of Actemra include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003erunny or \u003ca rel=\"nofollow\" href=\"https:\/\/www.rxlist.com\/stuffy_nose\/definition.htm\"\u003estuffy nose\u003c\/a\u003e,\u003c\/li\u003e\n\u003cli\u003e\n\u003ca rel=\"nofollow\" href=\"https:\/\/www.rxlist.com\/sinus\/definition.htm\"\u003esinus\u003c\/a\u003e pain,\u003c\/li\u003e\n\u003cli\u003e\n\u003ca rel=\"nofollow\" href=\"https:\/\/www.rxlist.com\/sore_throat\/symptoms.htm\"\u003esore throat\u003c\/a\u003e,\u003c\/li\u003e\n\u003cli\u003eheadache,\u003c\/li\u003e\n\u003cli\u003eincreased blood pressure,\u003c\/li\u003e\n\u003cli\u003eabnormal liver function tests, and\u003c\/li\u003e\n\u003cli\u003epain, swelling, burning, or irritation where the injection was given\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch4\u003eGeneral Considerations For Administration\u003c\/h4\u003e\n\u003cp\u003e   \u003cspan\u003eAvoid using ACTEMRA with biological DMARDs.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003e\u003cb\u003eStorage and Stability\u003c\/b\u003e\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003eDo not use beyond expiration date on the container, package, prefilled syringe, or autoinjector. ACTEMRA must be refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect the vials, syringes, and autoinjectors from light by storage in the original package until time of use, and keep syringes and autoinjectors dry.\u003c\/p\u003e\n\u003cp\u003e \u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e \u003cbr\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cul\u003e\u003c\/ul\u003e\n\u003ctable width=\"100%\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePhilippne FDA Info\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRegistration Number\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBR-689\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eGeneric Name\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eTocilizumab\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eBrand Name\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eActemra\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eDosage Strength\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e400mg \/ 20 mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eDosage Form\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eConcentrate For Solution For I.V. Infusion\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eClassification\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003ePrescription Drug (RX)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePackaging\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e20 mL colorless Type I glass vial per box (box of 1's)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eManufacturer\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eChugai Pharma Manufacturing Co., Limited\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCountry of Origin\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eJapan\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eTrader\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eF. Hoffmann-La Roche Limited - Switzerland\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eImporter\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eRoche (Philippines) Inc.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eDistributor\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eZuellig Pharma Corporation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eIssuance Date\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e18 June 2018\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eExpiry Date\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e20 March 2023\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e","brand":"Roche","offers":[{"title":"Vial 400mg (20ml)","offer_id":48942567260297,"sku":"202511272201","price":0.0,"currency_code":"USD","in_stock":true},{"title":"Vial 80mg (4ml)","offer_id":48942567293065,"sku":"202511272202","price":0.0,"currency_code":"USD","in_stock":true},{"title":"Vial 200mg (10ml)","offer_id":48942567325833,"sku":"202511272203","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0789\/6550\/6185\/files\/aCTEMra.png?v=1794275583","url":"https:\/\/shoplumvella.shop\/products\/actemra-tocilizumab","provider":"Elmwood Trading","version":"1.0","type":"link"}